I

Icagen

38 employees

ICAgen, a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Target-to-Lead
Chemistry
Ion Transporter Reseach
HTS
Integrated Drug Discovery
Ion Channel Research
Medical
Health Care
eADME

Date founded

1992

Funding rounds raised

I

Icagen raised undisclosed on January 1, 1997

Investors: Venrock

FAQ